aphrocallistin

an adenine-substituted bromotyramine metabolite from the Hexactinellida sponge Aphrocallistes beatrix; structure in first source

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Divlianska, Daniela B: 1 article (06/2009)
2.	Guzmán, Esther A: 1 article (06/2009)
3.	Hoffman, Jennifer K: 1 article (06/2009)
4.	Linley, Patricia: 1 article (06/2009)
5.	McCarthy, Peter J: 1 article (06/2009)
6.	Pechter, Diana: 1 article (06/2009)
7.	Pitts, Tara P: 1 article (06/2009)
8.	Pomponi, Shirley A: 1 article (06/2009)
9.	Reed, John K: 1 article (06/2009)
10.	Roth, Gregory P: 1 article (06/2009)

1.	Pancreatic Neoplasms (Pancreatic Cancer) 06/01/2009 - "Aphrocallistin inhibits the growth of a panel of human tumor cell lines with IC(50) values ranging from 7.5 to >100 microM and has been shown to induce G1 cell cycle arrest in the PANC-1 pancreatic carcinoma cell line. "
2.	Neoplasms (Cancer) 06/01/2009 - "Aphrocallistin has been fully characterized in the NCI cancer cell line panel and has undergone in vitro ADME pharmacological profiling."